Recent Finacing
Recent Raise
Aileens Pharma develops topical non‑steroidal treatments using patented ingredients to modulate the skin microbiome for atopic dermatitis, seborrheic dermatitis, and psoriasis, partnering with UNIMOL for formulation and clinical development.
